Market News / Story
Halozyme (HALO) Secures Injunction Blocking Keytruda SC in Parts of Europe
·
Halozyme won a court injunction stopping manufacture and sale of Merck’s Keytruda SC in multiple European markets. Material Details #DetailAI Analyst View1Injunction on Keytruda SC in EuropeDisrupts a high-profile product’s rollout, impacting competitor revenue and Halozyme’s IP leverage.2Blocks manufacture and saleImmediate commercial impact in affected markets; could shift near-term sales trajectories.3Applies to multiple marketsBroader scope raises revenue at risk…